Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease

Gene

Volumn 542, Issue 2, 2014, Pages 141-145

  Sheng, Jinghao ^a   Su, Liling ^a   Xu, Zhengping ^a   Chen, Guangdi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer's disease; Meta analysis; Polymorphism; Progranulin

Indexed keywords

ALZHEIMER'S DISEASE; META-ANALYSIS; POLYMORPHISM; PROGRANULIN;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84898832482     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.03.041     Document Type: Article

References (25)

1. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
2. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
3. Brouwers N., Sleegers K., Engelborghs S., Maurer-Stroh S., Gijselinck I., et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 2008, 71:656-664.
4. Chang K.H., Chen C.M., Chen Y.C., Hsiao Y.C., Huang C.C., et al. Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population. PLoS One 2013, 8:e54448.
5. Cortini F., Fenoglio C., Guidi I., Venturelli E., Pomati S., et al. Novel exon 1 progranulin gene variant in Alzheimer's disease. European Journal of Neurology 2008, 15:1111-1117.
6. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
7. Dickson D.W., Baker M., Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neuro-Degenerative Diseases 2010, 7:170-174.
8. Doi H., Tanaka F. The genetics of corticobasal syndrome. Brain and Nerve 2013, 65:19-30.
9. Fenoglio C., Galimberti D., Cortini F., Kauwe J.S., Cruchaga C., et al. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease. Journal of Alzheimer's Disease 2009, 18:603-612.
10. Hayashino Y., Noguchi Y., Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. Journal of Epidemiology 2005, 15:235-243.
11. Hsiung G.Y., Fok A., Feldman H.H., Rademakers R., Mackenzie I.R. rs5848 polymorphism and serum progranulin level. Journal of the Neurological Sciences 2011, 300:28-32.
12. Kamalainen A., Viswanathan J., Natunen T., Helisalmi S., Kauppinen T., et al. GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer's disease patients. Journal of Alzheimer's Disease 2013, 33:23-27.
13. Lee M.J., Chen T.F., Cheng T.W., Chiu M.J. rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population. Neuro-Degenerative Diseases 2011, 8:216-220.
14. Mateo I., Gonzalez-Aramburu I., Pozueta A., Vazquez-Higuera J.L., Rodriguez-Rodriguez E., et al. Reduced serum progranulin level might be associated with Parkinson's disease risk. European Journal of Neurology 2013, 20:1571-1573.
15. Moreno F., Alzualde A., Camblor P.M., Barandiaran M., Van Deerlin V.M., et al. Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation. Alzheimer Disease and Associated Disorders 2011, 25:93-95.
16. Nuytemans K., Pals P., Sleegers K., Engelborghs S., Corsmit E., et al. Progranulin variability has no major role in Parkinson disease genetic etiology. Neurology 2008, 71:1147-1151.
17. Pao W.C., Dickson D.W., Crook J.E., Finch N.A., Rademakers R., et al. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Disease and Associated Disorders 2011, 25:364-368.
18. Pereson S., Wils H., Kleinberger G., McGowan E., Vandewoestyne M., et al. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. The Journal of Pathology 2009, 219:173-181.
19. Piaceri I., Nacmias B., Sorbi S. Genetics of familial and sporadic Alzheimer's disease. Frontiers in Bioscience (Elite Edition) 2013, 5:167-177.
20. Prince M., Bryce R., Albanese E., Wimo A., Ribeiro W., et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013, 9(63-75):e2.
21. Rademakers R., Baker M., Gass J., Adamson J., Huey E.D., et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C->T (Arg493X) mutation: an international initiative. Lancet Neurology 2007, 6:857-868.
22. Rademakers R., Eriksen J.L., Baker M., Robinson T., Ahmed Z., et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Human Molecular Genetics 2008, 17:3631-3642.
23. Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam study. Archives of Neurology 1998, 55:964-968.
24. Venturelli E., Villa C., Fenoglio C., Clerici F., Marcone A., et al. BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease. Journal of Alzheimer's Disease 2011, 23:701-707.
25. Viswanathan J., Makinen P., Helisalmi S., Haapasalo A., Soininen H., et al. An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2009, 150B:747-750.